EQS-News: Cantourage Completes Third EU-GMP Certification Project and Secures Five-Year Exclusive Access to Premium Cannabis Products
|
EQS-News: Cantourage Group SE
/ Key word(s): Strategic Company Decision/Agreement
Cantourage Group SE (hereinafter “Cantourage”, ISIN: DE000A3DSV01) is further strengthening its position in the European medical cannabis market. With the successful EU-GMP certification of Canadian licensed processor 1530076 BC Ltd., Cantourage has now successfully completed its third strategic certification project, following Green Karat and LOT420. 1530076 BC Ltd. operates production facilities in British Columbia, Canada, and provides production services to premium cannabis cultivators in the province, including 1235009 BC LTD d.b.a. FN Canna, a cultivator whose products are available under All Nations and Uncle Bob brands. Cantourage has represented FN Canna in the European market since 2023. "This milestone belongs to our team. Achieving EU-GMP certification required months of rigorous preparation, documentation and process refinement, and our people met that challenge at every step. We are extremely proud of what they have accomplished. Our thanks also go to Cantourage, whose guidance and collaboration were instrumental in reaching this standard," says Hendrick Ng, Director of Quality of FN Canna. “Following Green Karat and LOT420, 1530076 BC Ltd. is now the third partner we have successfully supported through the EU-GMP certification process. Through our exclusivity agreements, we have secured long-term access to a strategically important part of our premium portfolio, including our well-established All Nations products, but also many more premium cannabis products manufactured in British Columbia. This represents a significant strategic competitive advantage. At the same time, we are demonstrating that Cantourage's regulatory expertise not only opens the door to the European market for international premium producers, but also enables us to secure long-term access to some of the most sought-after products,” says Philip Schetter, CEO of Cantourage Group SE. Through the long-term partnerships Cantourage has secured exclusive access to high-quality cannabis products from three internationally sought-after premium producers for a period of five years. This sustainably strengthens the company's competitive position while providing greater planning certainty regarding the availability of premium products that are in high demand. About 1530076 BC Ltd. 1530076 BC Ltd. Is a joint venture between Phyton Biotech LLC and First Nations Processing Corporation and is a licensed processor of cannabis products based in British Columbia, Canada. Its EU-GMP certification (certificate no. DE-ST-01-GMP-2026-36) covers the processing, primary packaging and in-process quality control of medicinal cannabis flowers that have not been treated with ionizing radiation for microbial reduction. The certification confirms that the company's processing facility has been assessed as meeting the EU standard for good manufacturing practices applicable to medicinal cannabis. The company currently processes on behalf of its client 1235009 B.C. Ltd. d.b.a. FN Canna and intends to extend its processing services to further premium growers. About Cantourage Cantourage is a leading European company specializing in the production and distribution of cannabis-based medical preparations and pharmaceutical products. With its experienced management team and its “Fast Track Access” platform, Cantourage enables producers from around the world to enter the growing European medical cannabis market more quickly, easily and cost-effectively by processing and distributing their cannabis raw materials and extracts. In doing so, Cantourage consistently ensures compliance with the highest European pharmaceutical quality standards. The company offers pharmaceutical-grade products across all relevant market segments: dried cannabis flower, extracts, dronabinol and cannabidiol. Cantourage was listed on the Frankfurt Stock Exchange on 11 November 2022 (ISIN: DE000A3DSV01).
05.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Cantourage Group SE |
| Feurigstraße 54 | |
| 10827 Berlin | |
| Germany | |
| E-mail: | info@cantourage.com |
| Internet: | https://www.cantourage.com/ |
| ISIN: | DE000A3DSV01 |
| WKN: | A3DSV0 |
| Listed: | Regulated Unofficial Market in Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 3912003NCTLO6YHA9V48 |
| EQS News ID: | 2429240 |
| End of News | EQS News Service |
|
|
2429240 05.11.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 0,53 | 5,22 | 14,16 | 23,56 | 50,91 | 92,80 | 90,00 | |
| EBITDA1,2 | -0,56 | -0,83 | -2,51 | -0,25 | 3,48 | 5,70 | 11,00 | |
| EBITDA-Margin3 | -105,66 | -15,90 | -17,73 | -1,06 | 6,84 | 6,14 | 12,22 | |
| EBIT1,4 | -0,59 | -0,97 | -6,32 | -4,33 | -0,72 | 4,00 | 0,00 | |
| EBIT-Margin5 | -111,32 | -18,58 | -44,63 | -18,38 | -1,42 | 4,31 | 0,00 | |
| Net Profit (Loss)1 | -0,59 | -0,97 | -5,92 | 4,27 | -1,14 | 3,00 | 0,00 | |
| Net-Margin6 | -111,32 | -18,58 | -41,81 | 18,12 | -2,24 | 3,23 | 0,00 | |
| Cashflow1,7 | -0,56 | -0,83 | -2,11 | -0,20 | 3,07 | 6,00 | 0,00 | |
| Earnings per share8 | -0,05 | -0,08 | -0,47 | -0,34 | -0,09 | 0,24 | 0,31 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PKF Wulf Gruppe
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Cantourage Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A3DSV0 | DE000A3DSV01 | SE | 55,61 Mio € | 11.11.2022 | Kaufen | 9F4MF9M4+93 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 11,74 | 14,26 | 0,82 | -44,60 | 1,43 | 18,14 | 0,60 |
|
Dividend '2024 in € |
Dividend '2025 in € |
Dividend '2026e in € |
Div.-Yield '2026e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 24.06.2026 | 11.05.2026 | 13.08.2026 | 10.11.2026 | 15.05.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -16,48% | -18,43% | +31,56% | +52,22% | -31,17% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.